Fosphenytoin Sodium

Fosphenytoin Sodium
(faws fen’ i toe in)
Cerebyx
PREGNANCY CATEGORY D
Drug Classes
Antiepileptic
Hydantoin
Therapeutic Actions
A prodrug that is converted to phenytoin; has antiepileptic activity without causing general CNS depression; stabilizes neuronal membranes and prevents hyperexcitability caused by excessive stimulation; limits the spread of seizure activity from an active focus.
Indications
  • Short-term control of general convulsive status epilepticus
  • Prevention and treatment of seizures occurring during or following neurosurgery
  • Short-term substitute for oral phenytoin
Available Forms
Injection—75 mg/mL (50 mg/mL phenytoin equivalents [PE])
Dosages
Dosage is given as PEs to facilitate transfer from phenytoin.
Adults
  • Status epilepticus: Loading dose of 15–20 mg PE/kg administered at 100–150 mg PE/min IV.
  • Neurosurgery (prophylaxis): Loading dose of 10–20 mg PE/kg IM or IV; maintenance dose of 4–6 mg PE/kg/day.
  • Substitution for oral phenytoin therapy: Substitute IM or IV at the same total daily dose as phenytoin, for short-term use only.
Pediatric patients
Not recommended; off-label use only.
Patients with renal or hepatic impairment
Use caution and monitor for early signs of toxicity—changes in the metabolism of the drug may result in increased risk of adverse effects.
Pharmacokinetics
Route Onset Peak
IV Rapid End of infusion

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in NURSING | Comments Off on Fosphenytoin Sodium

Full access? Get Clinical Tree

Get Clinical Tree app for offline access